Physician

Abdullah Abou-Samra, MD

According to 2025 Medicare claims, Abdullah Abou-Samra, MD (NPI: 1134757479) practices ophthalmology in the Washington, DC-MD market, with the plurality of this provider's patient population coming from The District, DC. This provider's primary affiliated billing organization is WASHINGTON NATIONAL EYE CENTER (NPI: 1437175684; TIN: 521325467) and primary practice location at 20010-2975. Abou-Samra is affiliated with the Physician Leaders Direct Contracting Entity, LLC (ACO ID: D0171) and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under the REACH model.

Abou-Samra's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 120 traditional Medicare patients, billed 220 HCPCS/CPT codes, and received $21,222 in Medicare payments. The top billing code was 67036 (Removal of eye fluid (vitreous) between lens and retina). Part D data shows 181 prescription claims across 63 beneficiaries totaling $5,072 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 9 records totaling $803. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, this provider has fewer than 5 years of reported Part D prescription costs data, so a reliable trend cannot be assigned. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$11K$21K2024 Medicare payment: $21,222 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024120220$21,222

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$128K$255K2021 Drug cost: $6,883 (USD; Tot_Drug_Cst)2022 Drug cost: $255,326 (USD; Tot_Drug_Cst)2023 Drug cost: $13,214 (USD; Tot_Drug_Cst)2024 Drug cost: $5,072 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
202158117$6,883
2022116421$255,326
202381287$13,214
202463181$5,072

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67036Removal of eye fluid (vitreous) between lens and retina1515$125
67028Injection of drug into eye2122$101
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more3741$98
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more1212$80
92134Imaging of retina5259$29

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate361,426$1,954
MoxifloxacinMoxifloxacin Hcl16229$426
Atropine SulfateAtropine Sulfate13490$382
LatanoprostLatanoprost431,655$243
OfloxacinOfloxacin14314$181

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.9$803Alcon Vision LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Abdullah Abou-Samra, MD?

Tedicare shows public-source Medicare data for Abdullah Abou-Samra, MD (NPI 1134757479), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abdullah Abou-Samra, MD have ACO affiliation data?

Abdullah Abou-Samra, MD is shown with ACO affiliation data for Physician Leaders Direct Contracting Entity, LLC (REACH, ACO ID D0171) and Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Abdullah Abou-Samra, MD?

Abdullah Abou-Samra, MD is linked to WASHINGTON NATIONAL EYE CENTER (billing NPI 1437175684) in the available physician profile data.

Does Abdullah Abou-Samra, MD have Open Payments data?

Abdullah Abou-Samra, MD has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.